ArticleInternational journal of women's health2026
Global Burden and Trends of Ischemic Heart Disease in Women Aged 55 years and Older, 1990-2021: A Systematic Analysis of the Global Burden of Disease Study 2021.
Article in International journal of women's health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To characterize the global burden and long-term trends of ischemic heart disease (IHD) among women aged ≥55 years, with particular attention to regional, socioeconomic and age-specific variation. Patients and methods: From the Global Burden of Disease Study 2021 we extracted disability-adjusted life-year (DALY), death and incidence counts and age-standardized rates (ASRs) for IHD in women aged ≥55 years across 204 countries, 21 regions and five Socio-demographic Index (SDI) strata. Estimated annual percentage changes (EAPCs) were derived by log-linear regression of ln (ASR) on calendar year. Trends were examined by region, by SDI and across nine five-year age bands from 55-59 to ≥95 years. Results: Globally, DALYs rose from 40.0 to 60.6 million (EAPC 1.23), deaths from 2.36 to 3.71 million (EAPC 1.39) and incident cases from 5.69 to 11.69 million (EAPC 2.20), while ASRs fell (DALY EAPC -1.53; death EAPC -1.60; incidence EAPC -0.57). Burden was highest in Central Asia (19,862.64/100 000), Eastern Europe (17,690.80) and North Africa and the Middle East (16,239.37), and lowest in the high-income Asia Pacific (1359.50), Australasia (2469.28) and Western Europe (2590.61). Western Europe (-4.46), Australasia (-5.27) and the high-income Asia Pacific (-3.83) declined fastest; East Asia (0.23), South Asia (0.00) and southern sub-Saharan Africa (0.65) rose or stayed flat. Incidence in women aged ≥95 years grew fastest (EAPC 4.49). Conclusion: Older women bear a growing absolute IHD burden whose age-standardized intensity is falling unevenly worldwide. These findings highlight the need for clinicians to recognize the increasing IHD burden in older women and for public health systems to incorporate age- and sex-specific burden patterns into preventive care and health-resource planning.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.